СПОСОБ ВОССТАНОВИТЕЛЬНОГО ЛЕЧЕНИЯ НЕРВНО-МЫШЕЧНОГО АППАРАТА У БОЛЬНЫХ С ЛОЖНЫМ СУСТАВОМ ШЕЙКИ БЕДРЕННОЙ КОСТИ ПОСЛЕ ЭНДОПРОТЕЗИРОВАНИЯ ТАЗОБЕДРЕННОГО СУСТАВА
GORJAKIN MAKSIM VLADIMIROVICH,Горякин Максим Владимирович,KORSHUNOVA GALINA ALEKSANDROVNA,Коршунова Галина Александровна,RESHETNIKOV ANDREJ NIKOLAEVICH,Решетников Андрей Николаевич,FROLENKOV ALEKSANDR
申请号:
RU2013128662/14
公开号:
RU0002528637C1
申请日:
2013.06.25
申请国别(地区):
RU
年份:
2014
代理人:
摘要:
FIELD: medicine.SUBSTANCE: method involves a preclinical electroneuromyography (ENMG) of the neuromuscular apparatus of injured and intact lower extremities to measure a muscle response amplitude - an M-response. The findings are recorded. Starting from the second postoperative day, in the course of the drug-induced neuroprotective treatment and therapeutic exercises, the following therapy is additionally performed for 10-15 days. If the injured M-response amplitude is below 4.0 mV, while the respective intact value is more than 4.0 mV, the anti-inflammatory physical treatment covering the injured extremity is performed. If the injured M-response amplitude is more than 4.0 mV, while the respective intact value is below 4.0 mV, the stimulating passive physical treatment covering the intact extremity is performed. If the M-response amplitude of the injured and intact extremities is below 4.0 mV, the anti-inflammatory physical treatment covering the injured extremity and the stimulating passive physical treatment covering the intact extremity are performed. Three and six months following the surgical management, the repeated ENMG of the neuromuscular apparatus of the lower extremities to measure the M-response amplitude. If observing the preserving M-response amplitude below 4.0 mV on at least one lower extremity three months following the surgical management, the repeated complex of the drug-induced neuroprotective treatment and the stimulating passive physical treatment covering the neuromuscular apparatus of the hip with the M-response amplitude below 4.0 mV are performed. If observing the preserving M-response amplitude below 4.0 mV on at least one lower extremity six months following the surgical management, the repeated complex of the drug-induced neuroprotective treatment and the stimulating passive physical functional treatment covering the neuromuscular apparatus of the hip with the M-response amplitude below 4.0 mV are performed by walking electrical stimulat